Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1962541466
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1303 McCullough Ave, Suite 374
San Antonio, TX, 78212
Phone (210) 223-5483
Groups this clinician bills Medicare through
Medicare paid, 2024
$395K
11,390 services
Medicare patients, 2024
1,128
Average age 75
Drug cost, 2024
$973K
4,366 prescriptions
Company payments, 2025
$4,306
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harry L Uy was code J0897 (injection, denosumab, 1 mg), 8,160 times for 83 patients. In total Harry L Uy billed 11,390 services in 19 codes, and Medicare paid $395K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 8,160 | 83 | $20.66 | $169K |
| 99214 Office E&M - Established | Office | 1,613 | 1,092 | $81.94 | $132K |
| 76536 Ultrasound - Nonspecific | Office | 557 | 530 | $71.94 | $40K |
| 77080 Standard X-ray | Office | 463 | 459 | $35.86 | $17K |
| 96401 Chemotherapy Administration | Office | 191 | 118 | $51.14 | $9,768 |
| 82962 Clinical Chemistry | Office | 85 | 58 | $3.17 | $270 |
| 99205 Office E&M - New | Office | 74 | 74 | $149.66 | $11K |
| 95251 Test - Miscellaneous | Office | 74 | 37 | $24.60 | $1,820 |
| 10005 Other Organ Systems | Office | 49 | 44 | $92.50 | $4,533 |
| 10006 Other Organ Systems | Office | 41 | 28 | $41.54 | $1,703 |
| 99215 Office E&M - Established | Office | 25 | 24 | $113.24 | $2,831 |
| 99213 Office E&M - Established | Office | 20 | 19 | $57.02 | $1,140 |
By year: 2022 $261K for 8,399 services; 2023 $334K for 10,474 services; 2024 $395K for 11,390 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 85 | 58 | $3.17 | $270 |
Medicare prescription drug claims, 2024
In 2024, the drug Harry L Uy prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,329 prescriptions and refills. In total Harry L Uy wrote 4,366 Medicare prescriptions that cost $973K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,329 | 3,870 | 400 | $16K |
| Ibandronate Sodium Generic | 397 | 1,153 | 143 | $13K |
| Atorvastatin Calcium Generic | 225 | 667 | 72 | $1,899 |
| Rosuvastatin Calcium Generic | 218 | 611 | 70 | $2,503 |
| Metformin Hcl Generic | 189 | 556 | 67 | $1,293 |
| Synthroid Levothyroxine Sodium | 151 | 436 | 51 | $11K |
| Alendronate Sodium Generic | 126 | 344 | 37 | $1,087 |
| Prolia Denosumab | 123 | 734 | 83 | $207K |
| Glimepiride Generic | 103 | 304 | 37 | $1,116 |
| Ezetimibe Generic | 82 | 246 | 27 | $3,508 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 75 | 207 | 26 | $1,101 |
| Jardiance Empagliflozin | 58 | 170 | 23 | $95K |
| Ozempic Semaglutide | 57 | 77 | 11 | $70K |
| Pravastatin Sodium Generic | 51 | 151 | 16 | $749 |
| Tresiba Flextouch U-200 Insulin Degludec | 42 | 86 | 14 | $46K |
Brand drugs: 1,306 claims; generic drugs: 2,925 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harry L Uy $4,306 ($4,306 in general payments such as food, travel and fees) from 35 companies. The largest payer was Amgen Inc. with $648.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.